AbbVie
ABBV
#26
Rank
S$517.80 B
Marketcap
S$292.98
Share price
-1.15%
Change (1 day)
27.66%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total assets

Total assets on the balance sheet as of September 2025 : S$173.51 Billion

According to AbbVie's latest financial reports the company's total assets are S$173.51 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

AbbVie - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2024-12-31S$183.72 B3.26%
2023-12-31S$177.91 B-4.39%
2022-12-31S$186.08 B-6.06%
2021-12-31S$198.09 B-0.55%
2020-12-31S$199.18 B65.79%
2019-12-31S$120.14 B48.17%
2018-12-31S$81.08 B-14.36%
2017-12-31S$94.67 B-1.03%
2016-12-31S$95.66 B27.48%
2015-12-31S$75.04 B106.42%
2014-12-31S$36.35 B-1.73%
2013-12-31S$36.99 B12.01%
2012-12-31S$33.02 B30.65%
2011-12-31S$25.28 B-7.14%
2010-12-31S$27.22 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
S$270.49 B 55.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$125.55 B-27.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$148.94 B-14.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$116.81 B-32.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$75.85 B-56.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$37.84 B-78.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$106.86 B-38.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
S$148.32 B-14.52%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
S$5.52 B-96.81%๐Ÿ‡บ๐Ÿ‡ธ USA